← all drugs
Dextrose Monohydrate 50% Injection
in shortage · Endocrinology/Metabolism · Snapshot: 2026-10-09
Day 1,730
of this shortage, counting from the FDA's first posting on 01/13/2022
- Manufacturers listed
- Amphastar Pharmaceuticals, Inc., Hospira, Inc., a Pfizer Company
- Reported reason(s)
- Other
- Machine-readable
- JSON for this drug
Presentations (4)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1) | Amphastar Pharmaceuticals, Inc. | Available | 09/16/2026 |
| Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02) | Hospira, Inc., a Pfizer Company | Limited Availability | 08/24/2026 |
| Dextrose Monohydrate 50%, Injection, 50% Dextrose Injection 0.5 g/mL; ABBOJECT® Glass Syringe (NDC 0409-4902-34) | Hospira, Inc., a Pfizer Company | unknown | 11/07/2025 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-12 — Dextrose Monohydrate 50% Injection: availability wording revised for 2 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.